Found: 7
Select item for more details and to access through your institution.
Agreement between one stage and chromogenic assays in samples from patients receiving recombinant porcine FVIII (Obizur, Susoctocog‐alfa).
- Published in:
- International Journal of Laboratory Hematology, 2024, v. 46, n. 1, p. 135, doi. 10.1111/ijlh.14181
- By:
- Publication type:
- Article
The combination of emicizumab and recombinant factor VIII in plasma: Which assays can we use for accurate measurement?
- Published in:
- International Journal of Laboratory Hematology, 2023, v. 45, n. 3, p. 368, doi. 10.1111/ijlh.14021
- By:
- Publication type:
- Article
Measurement of extended half‐life recombinant factor IX products in clinical practice.
- Published in:
- International Journal of Laboratory Hematology, 2019, v. 41, n. 2, p. e46, doi. 10.1111/ijlh.12953
- By:
- Publication type:
- Article
Management of acute pulmonary embolism.
- Published in:
- British Journal of Hospital Medicine (17508460), 2015, v. 76, n. 10, p. C150, doi. 10.12968/hmed.2015.76.10.C150
- By:
- Publication type:
- Article
High concentrations of coagulation factor VIII and thrombosis: is the factor VIII-binding domain of von Willebrand factor implicated?
- Published in:
- British Journal of Haematology, 2001, v. 113, n. 3, p. 655, doi. 10.1046/j.1365-2141.2001.02830.x
- By:
- Publication type:
- Article
Caution in Using the Activated Partial Thromboplastin Time to Monitor Argatroban in COVID-19 and Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT).
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2021, v. 27, p. 1, doi. 10.1177/10760296211066945
- By:
- Publication type:
- Article
Factor V Leiden and the common haemochromatosis mutation HFE C282Y: is there an association in familial venous thromboembolic disease?
- Published in:
- British Journal of Haematology, 1999, v. 107, n. 1, p. 210, doi. 10.1046/j.1365-2141.1999.01663.x
- By:
- Publication type:
- Article